Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11089908rdf:typepubmed:Citationlld:pubmed
pubmed-article:11089908lifeskim:mentionsumls-concept:C0085112lld:lifeskim
pubmed-article:11089908lifeskim:mentionsumls-concept:C0011777lld:lifeskim
pubmed-article:11089908lifeskim:mentionsumls-concept:C0020522lld:lifeskim
pubmed-article:11089908lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:11089908lifeskim:mentionsumls-concept:C0301625lld:lifeskim
pubmed-article:11089908pubmed:issue10lld:pubmed
pubmed-article:11089908pubmed:dateCreated2001-2-23lld:pubmed
pubmed-article:11089908pubmed:abstractTextIt is not known whether the amelioration of inflammation by corticosteroids is mediated through a direct effect on the T cells or by effects on other inflammatory cells and/or their products. To explore the mechanisms whereby corticosteroids exert their effects on T cell dependent inflammation we have used severe combined immunodeficiency (SCID) mice. These mice are largely devoid of functional T and B lymphocytes, hence being unable to raise delayed type hypersensitivity (DTH), but display intact antigen presenting capacity. The aim of this study was to analyse the target cell population participating in DTH and being affected by corticosteroid treatment.lld:pubmed
pubmed-article:11089908pubmed:languageenglld:pubmed
pubmed-article:11089908pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11089908pubmed:citationSubsetIMlld:pubmed
pubmed-article:11089908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11089908pubmed:statusMEDLINElld:pubmed
pubmed-article:11089908pubmed:monthOctlld:pubmed
pubmed-article:11089908pubmed:issn1023-3830lld:pubmed
pubmed-article:11089908pubmed:authorpubmed-author:CarlstenHHlld:pubmed
pubmed-article:11089908pubmed:authorpubmed-author:TaubeMMlld:pubmed
pubmed-article:11089908pubmed:issnTypePrintlld:pubmed
pubmed-article:11089908pubmed:volume49lld:pubmed
pubmed-article:11089908pubmed:ownerNLMlld:pubmed
pubmed-article:11089908pubmed:authorsCompleteYlld:pubmed
pubmed-article:11089908pubmed:pagination548-52lld:pubmed
pubmed-article:11089908pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11089908pubmed:meshHeadingpubmed-meshheading:11089908...lld:pubmed
pubmed-article:11089908pubmed:meshHeadingpubmed-meshheading:11089908...lld:pubmed
pubmed-article:11089908pubmed:meshHeadingpubmed-meshheading:11089908...lld:pubmed
pubmed-article:11089908pubmed:meshHeadingpubmed-meshheading:11089908...lld:pubmed
pubmed-article:11089908pubmed:meshHeadingpubmed-meshheading:11089908...lld:pubmed
pubmed-article:11089908pubmed:meshHeadingpubmed-meshheading:11089908...lld:pubmed
pubmed-article:11089908pubmed:meshHeadingpubmed-meshheading:11089908...lld:pubmed
pubmed-article:11089908pubmed:meshHeadingpubmed-meshheading:11089908...lld:pubmed
pubmed-article:11089908pubmed:meshHeadingpubmed-meshheading:11089908...lld:pubmed
pubmed-article:11089908pubmed:meshHeadingpubmed-meshheading:11089908...lld:pubmed
pubmed-article:11089908pubmed:year2000lld:pubmed
pubmed-article:11089908pubmed:articleTitleAction of dexamethasone in the suppression of delayed-type hypersensitivity in reconstituted SCID mice.lld:pubmed
pubmed-article:11089908pubmed:affiliationDepartment of Rheumatology, University of Göteborg, Sweden. maria.taube@immuno.gu.selld:pubmed
pubmed-article:11089908pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11089908pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed